Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
|
By LabMedica International staff writers Posted on 18 Nov 2019 |

Illustration
Systec GmbH (Nuremberg, Germany) launched the first product from its re-designed Systec H-Series: the new and improved Systec HX-150 autoclave at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. In addition to the new generation of autoclaves, visitors at MEDICA 2019 got a closer look at several other Systec devices, including not only autoclaves, but also advanced media preparators and the Systec Mediafill dispensing and dosing system. Systec’s partner company Evidencia GmbH also introduced innovative concepts for qualifying and validating equipment and sterilization processes.
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- Erba Mannheim Showcases New Launches at MEDICA 2019
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read more
Blood Test Detects More High-Risk Prostate Cancers Than PSA
Prostate cancer is one of the most common malignancies in men, and screening often struggles to distinguish indolent tumors from clinically significant disease. Prostate-specific antigen (PSA) testing... Read moreMolecular Diagnostics
view channel
Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers
Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more
Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease
Women show distinct susceptibility to infectious diseases and higher rates of autoimmune disorders, yet the molecular drivers remain unclear. This gap has limited sex-specific diagnostic and prognostic tools.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Lung Immune Profiling Reveals Distinct Severe Pneumonia Subtypes
Severe pneumonia often progresses to respiratory failure requiring intensive care and mechanical ventilation. Despite similar clinical presentations, outcomes vary widely, complicating decisions on an... Read more
Lab-on-a-Chip Approach Advances Immune–Cancer Cell Interaction Analysis
Conventional cytotoxicity assays often average responses across thousands of cells, obscuring how individual immune cells engage and kill tumor cells. For immunotherapy evaluation, the precise sequence... Read moreMicrobiology
view channel
Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more
Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more
Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more
Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read morePathology
view channel
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read more
Study Highlights Biomarker Testing Delays in Lung Cancer Care
Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Agreement Supports pTau217-Based Alzheimer’s Blood Test Development
As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more









